Revenue
$2.58B
Fiscal year ended 2026-06-30Operating income
-$154.52M
Fiscal year ended 2026-06-30Free cash flow
Unavailable
Fiscal year ended 2026-06-30Hims & Hers Health, Inc. (HIMS) reported revenue of $2.58B and net income of -$142.03M for the fiscal year ended 2026-06-30. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from Hims & Hers Health, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Services-Offices & Clinics of Doctors of Medicine.
Income
| Metric | 2026-06-30 |
|---|---|
| Revenue | $2.58B |
| Cost of revenue | $814.03M |
| Gross profit | $1.76B |
| Operating income | -$154.52M |
| Net income | -$142.03M |
| Research & development | Unavailable |
| Weighted-average diluted shares | Unavailable |
| Pretax income | -$163.61M |
| Income tax expense | -$21.58M |
| Diluted EPS | Unavailable |
| Selling, general & administrative | Unavailable |
| General & administrative | $431.89M |
| Selling & marketing | Unavailable |
Balance
| Metric | 2026-06-30 |
|---|---|
| Cash & equivalents | $609.81M |
| Total assets | $3.63B |
| Current assets | $1.38B |
| Total liabilities | $3.30B |
| Current liabilities | $1.48B |
| Total equity incl. NCI | $324.07M |
| Temporary (mezzanine) equity | Unavailable |
| Inventory | $87.78M |
| Accounts receivable | $375.29M |
| Goodwill | $1.10B |
| Long-term debt | Unavailable |
| Accounts payable | $501.30M |
Cash flow
| Metric | 2026-06-30 |
|---|---|
| Operating cash flow | $263.45M |
| Capital expenditures | Unavailable |
| Investing cash flow | -$901.98M |
| Financing cash flow | $127.34M |
| Net change in cash | -$515.14M |
| Stock-based compensation | $153.64M |
| Common dividends paid | Unavailable |
| Common share repurchases | Unavailable |
| Depreciation & amortization | $87.19M |
Derived
| Metric | 2026-06-30 |
|---|---|
| Free cash flow | Unavailable |
| Gross margin | 68.4% |
| Operating margin | -6.0% |
| FCF margin | Unavailable |
| SBC / revenue | 6.0% |
| Current ratio | 0.93x |
| Revenue YoY growth | 28.0% |
| Net margin | -5.5% |
| R&D / revenue | Unavailable |
| CapEx / revenue | Unavailable |
| Long-term debt / equity | Unavailable |
| Effective tax rate | Unavailable |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open HIMS in the interactive workspace to inspect any figure back to its filing.
Source filings
10-Q · Filed 2026-08-10View SEC filing
10-Q · Filed 2026-05-11View SEC filing
10-K · Filed 2026-02-23View SEC filing
10-Q · Filed 2025-11-03View SEC filing
10-Q · Filed 2025-08-04View SEC filing
10-Q · Filed 2025-05-05View SEC filing
Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.